Notion of using herceptin only for HER2-positive breast cancer challenged
Tuesday, February 26, 2013 - 21:00
in Health & Medicine
New research finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative – and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.